Fitzgerald Thomas A - Insider Non-Derivative Transactions at Transcode Therapeutics, Inc. (RNAZ) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 28, 2023, Fitzgerald Thomas A's relationship to Transcode Therapeutics, Inc. (RNAZ) is Director,Officer (Chief Financial Officer), and currently has 56,318 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNAZ insiders.
Data Source: SEC.
Fitzgerald Thomas A - Insider Non-Derivative Transactions at RNAZ
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 29, 2023 | P -- (Common Stock) | 49350 | 0.51 | 56318 |